A 52-year-old man from Delhi presents with a 3-month history of progressive dysphagia and weight loss. Upper endoscopy reveals a 4 cm ulcerated lesion in the lower third of the esophagus. Biopsy confirms adenocarcinoma. CT chest and abdomen shows no distant metastases, but there is involvement of the gastroesophageal junction. What is the most appropriate next step in management?
A. PET-CT for detection of occult metastases
B. Immediate palliative chemotherapy with 5-FU and cisplatin
C. Surgical resection without further staging
D. Endoscopic ultrasound (EUS) with fine-needle aspiration for lymph node staging
Explanation
Rationale for EUS in Esophageal Cancer Staging
Key Point
Endoscopic ultrasound (EUS) is the gold standard for locoregional staging of esophageal cancer, particularly for T-stage (depth of invasion) and N-stage (lymph node involvement) assessment.
Why EUS Is the Next Step
1.
T-stage determination: EUS can accurately assess the depth of tumor invasion (T1–T4) with 85–90% accuracy, which is critical for treatment planning.
Treatment stratification: The combination of T and N staging from EUS helps determine candidacy for:
Neoadjuvant chemoradiation (T3–T4 or N+)
Curative surgical resection
Palliative approaches
Staging Workflow for Esophageal Cancer
Loading diagram...
High-YieldNEET PG
In this patient with locally advanced disease (4 cm lesion with GEJ involvement), EUS is essential before committing to neoadjuvant therapy or surgery.
Clinical Pearl
PET-CT is used for M-staging (distant metastases) after locoregional staging is complete, not as the initial staging modality.
Robbins 10e Ch 15
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.